https://oncocyte-ocx.reportablenews.com daily 1.0 https://oncocyte-ocx.reportablenews.com/pr/meet-gisela-a-paulsen-mpharm-president-and-chief-operating-officer-at-oncocyte 2022-10-04T13:19:35Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/oncocyte-corporation-nasdaq-ocx-reports-on-2022-financial-results-and-provides-corporate-update 2022-09-19T10:43:53Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/oncocyte-announces-development-and-co-marketing-agreement-with-thermo-fisher-scientific-to-expand-access-to-precision-oncology 2022-03-07T11:56:29Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/oncocyte-business-call-update 2022-02-21T11:14:39Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/oncocyte-third-quarter-2021-financial-results-and-corporate-update 2022-01-13T10:31:38Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/from-the-desk-of-mitch-levine-cfo-oncocyte 2021-11-18T14:32:00Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/oncocyte-corporation-report-from-the-q2-2021-earnings-conference-call 2021-11-03T14:15:42Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/determaio-in-triple-negative-breast-cancer 2021-10-27T12:58:11Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/a-triple-play-capital-raise 2021-08-16T15:03:21Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/meetings-milestones-acquisitions 2021-08-05T16:22:07Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/setting-the-stage-for-2021-oncocyte-nasdaq-ocx 2021-05-06T16:01:35Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/novel-biomarkers-in-identifying-appropriate-responders-to-immune-checkpoint-inhibitors 2021-04-14T12:35:55Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/keeping-its-eye-on-the-ball 2021-02-16T14:38:09Z monthly 0.5 https://oncocyte-ocx.reportablenews.com/pr/kol-call-oncocyte-cancer 2020-12-06T22:11:37Z monthly 0.5